InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by HUNT RONALD, Director. Officer active across 3 companies, notably Rallybio Corp. In total, 5 disclosures have been recorded. Total volume traded: €6.6m. The latest transaction was disclosed on 11 January 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
36,798 shares
Ordinary Shares
SEC:0001209191-22-039314:0·
€3m235,294 shares@ €13.9502100.0% of flow
Common Stock
SEC:0000899243-21-032747·
Ideal exit: 8 Oct 2021 (T+270)
€3m235,294 shares@ €13.950250.0% of flow
Common Stock
SEC:0000899243-21-032747:0·
Ideal exit: 8 Oct 2021 (T+270)
1,993,911 shares
Common Stock
SEC:0000899243-21-031634·
1,993,911 shares
Common Stock
SEC:0000899243-21-031634:0·
5 of 5 declarations
About HUNT RONALD
Ronald Hunt is a Board Member at Rallybio Corp, Harpoon Therapeutics, Inc., and Iterum Therapeutics plc. He is involved in governance and strategic decision-making for each of these companies. With expertise in the biopharmaceutical sector, Ronald contributes to innovation and sustainability within the organizations.
